Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Allografting to Establish Mixed or Full Donor Chimerism as Consolidative Immunotherapy for Older Patients With AML in Complete Remission Using Low Dose TBI, PBSC Infusion and Post-Transplant Immunosuppression With Cyclosporine and Mycophenolate Mofetil

NCT00005801 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT00005801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00005801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Allografting to Establish Mixed or Full Donor Chimerism as Consolidative Immunotherapy for Older Patients With AML in Complete Remission Using Low Dose TBI, PBSC Infusion and Post-Transplant Immunosuppression With Cyclosporine and Mycophenolate Mofetil
Lead sponsor
University of Colorado, Denver
Phase
Phase 2
Overall status
Completed
Start date
November 30, 1999
Completion date
September 30, 2001
Enrollment
Not reported
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia